Bendazac

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Bendazac
Bendazac.svg
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Topical
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.039.594 Edit this at Wikidata
Chemical and physical data
FormulaC16H14N2O3
Molar mass282.294 g/mol g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Bendazac (or bendazolic acid) is a nonsteroidal anti-inflammatory drug (NSAID) used for joint and muscular pain.

Synthesis[edit]

Principal action is inhibition of protein denaturation.

Bendazac synthesis: BE 699226 ; G. Palazzo, U.S. Patent 3,470,194 (1967, 1969 both to Francesco Angelini).

Use of chloroacetamide in the alkylation step, followed by acid hydrolysis produces bendazac (instead of benzydamine).

See also[edit]

References[edit]